Overview
Lyophilisation removes water from a frozen material by sublimation under vacuum. What remains is a dry, porous solid that, when stored appropriately, usually degrades considerably more slowly than a solution. Many research peptides are therefore supplied in lyophilised form.
Scientific background
The three process stages
Freezing. The aqueous solution is cooled until ice crystals form. Dissolved substances become concentrated in the spaces between them (the freeze concentrate). If the solute does not crystallise, the freeze concentrate solidifies into an amorphous glass below its glass transition temperature Tg′; crystalline systems are characterised by their eutectic temperature.
Primary drying. The chamber pressure is lowered substantially and heat is supplied to the shelves in a controlled manner. The ice sublimes, and the water vapour is deposited on the much colder condenser. The product temperature must remain below the collapse temperature; otherwise the porous structure loses its support and slumps.
Secondary drying. The temperature is then raised to remove adsorbed water as well. The residual moisture that remains is a key factor in storage stability and is usually measured by Karl Fischer titration.
Why peptides are lyophilised
In solution, degradation reactions such as hydrolysis, deamidation or aggregation proceed comparatively quickly. In the dry solid, molecular mobility is severely restricted, so these reactions slow down considerably. After preparative HPLC, freeze-drying is also the usual way of gently isolating the peptide from the aqueous-organic eluate. Non-volatile components such as counterions remain in the product.
The lyophilisate
A well-made lyophilisate forms a uniform, porous cake or a loose powder. Shrunken, collapsed or glassy, melted-looking areas point to process deviations. Lyophilisates have a large internal surface area and are usually hygroscopic: they take up atmospheric moisture quickly, especially when a cold container is opened in warm room air and condensation forms.
Excipients
In pharmaceutical protein formulations, sugars such as sucrose or trehalose protect the structure during drying and storage. Research peptides, by contrast, are often freeze-dried without such excipients; their stability then depends more heavily on sequence, residual moisture and storage conditions.
Molecular data
No molecular data is recorded for this entry.
State of research
The physical principles of freeze-drying are well described; review articles such as Wang (2000) summarise the state of knowledge for proteins and peptides. Current developments concern controlled ice nucleation, in-process measurement technology and model-based process design.
Sources
The sources for this entry are currently being verified by the editorial team and will appear once verified.
Safety and research notes
- Lyophilised powders are light and often electrostatically charged. Use a weighing enclosure or fume hood when weighing, and avoid generating or inhaling dust.
- Freeze-dryers work with vacuum and very cold condenser surfaces. Avoid contact with bare skin and vent the chamber only after the process has finished, following the operating instructions.
- Allow lyophilisates to reach room temperature before opening to prevent condensation.
- For research use only. Not for use in humans or animals.